E. Jager

发表

Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy.

J. Karbach, M. Lichinitser, S. Nedospasov, 2005, Immunology letters.

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

V. Cerundolo, L. Old, E. Stockert, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3

N. Cascinelli, J. Naeyaert, J. Canon, 1995, International journal of cancer.

Anticorps se liant à mage a3

A. Knuth, C. Esslinger, M. Treder, 2012 .

vector T cells by bacterial + Induction of regulatory T cellresistant helper CD4

L. Old, G. Briones, G. Ritter, 2008 .

Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma--a multicenter phase II study.

L. Bergmann, A. Knuth, D. Hoelzer, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

NY‐ESO‐1 protein glycosylated by yeast induces enhanced immune responses

E. Fischer, J. Karbach, V. Cerundolo, 2010, Yeast.

Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.

R. Henschler, T. Zollner, W. Boehncke, 2004, Cancer research.

The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors

M. Mottolese, A. Santoni, P. Natali, 2006, Clinical Cancer Research.

Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.

J. Condeelis, M. Alessio, A. Santoni, 2007, Cancer research.

Human mena protein, a serex‐defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T‐cell immune response

M. Mottolese, A. Santoni, P. Natali, 2004, International journal of cancer.

Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients

J. Karbach, I. Lavrik, S. Nedospasov, 2008, Cancer Immunology, Immunotherapy.

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m2 Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

N. Harbeck, G. von Minckwitz, J. Sehouli, 2006, Oncology.

5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.

B. Seliger, M. Maio, A. Engelsberg, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Systemic Hyperthermia Oncologic Working Group Trial

D. Jäger, J. Dijk, D. Katschinski, 2003, Oncology.

Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen.

J. Karbach, L. Old, D. Valmori, 2007, Clinical immunology.

The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial

G. von Minckwitz, J. Sehouli, U. Kleeberg, 2006, British Journal of Cancer.

Antibody response to a non‐conserved C‐terminal part of human histone deacetylase 3 in colon cancer patients

M. Lichinitser, S. Nedospasov, D. Kuprash, 2005, International journal of cancer.

5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.

B. Seliger, M. Maio, A. Engelsberg, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.